References
- Clark RH, The Near-Term Respiratory Failure Research Group. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol 2005;25:251-7
- Engle WA. ‘Late-preterm’ infants: a population at risk. Pediatrics 2007;120:1390-401
- Finer NN, Barrington KJ. Nitric oxide therapy for the newborn infant. Semin Perinatol 2000;24:59-65
- Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Syst Rev 2006, Issue r. Art. No.: CD000399. doi: 10.1002/14651858.CD000399.pub2
- The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604
- Davidson D, Barefield ES, Kattwinkel J, et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics 1998;101:325-34
- Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000;342:469-74
- Lonnqvist PA, Winberg P, Lundell B, et al. Inhaled nitric oxide in neonates and children with pulmonary hypertension. Acta Paediatr 1994;83:1132-6
- Hoffman GM, Ross GA, Day SE, et al. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 1997;25:352-9
- Truog WE, Castor CA, Sheffield MJ. Neonatal nitric oxide use: predictors of response and financial implications. J Perinatol 2003;23:128-32
- Kennaugh JM, Kinsella JP, Abman SH, et al. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol 1997;17:366-9
- Angus DC, Clermont G, Watson RS, et al. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics 2003;112:1351-60
- Lorch SA, Cnaan A, Barnhart K. Cost-effectiveness of inhaled nitric oxide for the management of persistent pulmonary hypertension of the newborn. Pediatrics 2004;114:417-26
- Gonzalez A, Fabres J, D’Apremont I, et al. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension. J Perinatol 2010;30:420-4
- Pawlik TD, Porta NFM, Steinhorn RH, et al. Medical and financial impact of a neonatal extracorporeal membrane oxygenation referral center in the nitric oxide era. Pediatrics 2009;123:e17-e24
- Friedman B, De La Mare J, Andrews R, et al. Practical options for estimating cost of hospital inpatient stays. J Health Care Financ 2002;29:1-13
- Dasta JF, McLaughlin TP, Mody SH, et al. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med 2005;33:1266-71
- Agency for Healthcare Research and Quality. Rockville, MD: National estimates on use of hospitals by children from the HCUP Kids’ Inpatient Database (KID). HCUPnet. National Statistics on Children. ICD-9-CM procedure code 99.60 (cardiopulmonary resuscitation) for 2006 median costs for all hospitals. Available at: http://hcupnet.ahrq.gov/HCUPnet.jsp?Id=10271465CCAA2498&form=SelLAY&JS=Y&Action=%3E%3ENext%3E%3E&GoTo=MAINSEL [Last accessed 12 May 2010]